- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Orphan products
- Glyceryl tri-(4-phenylbutyrate)
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Glyceryl tri-(4-phenylbutyrate)
EU orphan designation number: | EU/3/10/735
![]() |
Active ingredient: | Glyceryl tri-(4-phenylbutyrate) |
Indication: | Treatment of citrullinaemia type 1 |
Sponsor: | Horizon Pharma Ireland Limited
Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, D04 C5Y6, Ireland |
EU Centralised marketing authorisation: | A centralised EU marketing authorisation has been obtained under the name Ravicti on 27/11/2015 with the number EU/1/15/1062 |
Public summary of scientific opinion
EPAR
European Commission procedures |